10 results
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications Summary ... GLP-1 receptor agonists ... EricsMedicalLectures/featured ... #comparison #management ... endocrinology #dm2
Summary of the therapeutic uses of adrenergic agonists
Table of Catecholamine Pressors, Non-Catecholamines, Alpha and Beta Receptor
Summary of the therapeutic ... uses of adrenergic ... agonists Table ... #Alpha #Beta #Table ... #Comparison
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
GLP-1 Receptor Agonists ... Ozempic), or daily tablet ... not definitively cause ... EricsMedicalLectures/featured ... #DM2 #diabetes
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
- Pharmacology Summary ... GLP-I receptor agonist ... not definitively cause ... EricsMedicalLectures/featured ... #DM2 #diabetes
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Medication Guide Classes ... GLP-1 receptor agonist ... Diabetes #Mellitus #DM2 ... #pharmacology #comparison ... #table #endocrinology
Rapid, increasing signs of extrapyramidal symptoms (EPS) is an important key feature of NMS. EPS, associated
important key feature ... about 95% of NMS cases ... of a dopamine agonist ... NeurolepticMalignant #Comparison ... #Table
Acromegaly - Diagnosis and Management Summary - GrepMed Handbook 

Clinical Presentation: 
 • Classic Acromegaly: frontal
and Management Summary ... coarsening facial features ... Pegvisomant) ± D2 ... agonist (Carbergoline ... or refractory cases
Sarcoidosis - Diagnosis and Management Summary
Epidemiology
1) High incidence in Scandinavian countries (11-24 cases per 100,000 individuals
and Management Summary ... failure Clinical Features ... symptoms are not caused ... Self-limiting, chronic but stable ... peripheral lymph nodes
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
Cardiomyopathy - Summary ... exclude other causes ... Planning for delivery mode ... during Delivery • Stable ... Bromocriptine, a dopamine agonist
Hyperthermic Toxidromes
Five toxidromes may present with overlapping features: hyperthermia, rhabdomyolysis, altered mental status/seizures.
 • Sympathomimetic -
with overlapping features ... cessation of dopamine agonists ... pharmacogenetic disease caused ... Hyperthermic #Toxidromes #comparison ... #table #diagnosis